Publication | Open Access
Vandetanib Improves Anti-Tumor Effects of L19mTNFα in Xenograft Models of Esophageal Cancer
18
Citations
27
References
2010
Year
These findings indicate that a combination of vascular damaging agents with anti-angiogenic drugs could represent a promising therapeutic strategy for esophageal cancer.
| Year | Citations | |
|---|---|---|
Page 1
Page 1